.
use
studi
smoke
covid-19
patient
increas
health
et
report
associ
also
includ
particip
risk
=
may
data
tobacco
effect
differ
among
,
sever
result
2
cell
compar
diseas
lung
higher
group
level
smoker
1
al.,
factor
chang
show
cigarett
one
found
signific
current
however,
age
infect
time
activ
research
rate
express
provid
number
sampl
test
al.
could
like
respiratori
nicotin
exposur
tabl
respons
model
high
measur
present
control
e-cigarett
clinic
product
p
inform
assess
gener
two
find
due
indic
develop
alcohol
reduc
individu
3
social
popul
analysi
year
observ
suggest
preval
potenti
).
treatment
peopl
case
de
relat
follow
identifi
pandem
support
quit
figur
survey
lower
base
significantli
first
import
substanc
medic
outcom
less
copd
need
posit
caus
symptom
public
consid
hospit
student
avail
score
behavior
variabl
impact
decreas
conduct
well
<
limit
cessat
day
shown
perform
intervent
care
within
statist
three
prevent
chronic
similar
work
4
evid
system
(
vape
would
per
10
5
adult
mani
type
total
although
mean
user
specif
possibl
review
ace2
mortal
estim
previou
protein
gene
sars-cov-2
physic
recent
collect
preprint
addit
drug
cancer
without
affect
human
function
lead
consist
study,
pulmonari
low
evalu
determin
complet
stress
6
consumpt
correl
valu
death
requir
major
examin
neg
analys
mental
initi
describ
respond
subject
accord
improv
sinc
cannabi
repres
whether
investig
role
women
statu
r
might
countri
protect
air
viral
continu
regard
acut
condit
involv
concentr
rang
state
across
obtain
greater
primari
(n
nation
educ
question
demonstr
given
depend
asthma
male
set
contribut
larg
remain
95%
made
influenc
receiv
young
select
rel
immun
la
e
airway
new
access
commun
method
intern
licens
common
contain
mechan
characterist
even
30
implement
least
experi
polici
(p
author
12
month
perceiv
adjust
version
viru
detect
proport
2020)
univers
allow
live
therefore,
relationship
regress
promot
multipl
femal
n
period
target
confirm
interact
expos
drink
help
standard
addition,
size
children
form
process
program
behaviour
(e.g.,
blood
prior
approach
area
smoking,
medrxiv
tissu
study.
refer
vaccin
qualiti
anoth
past
display
onlin
use,
depress
design
harm
frequenc
end
±
earli
person
daili
small
ask
adolesc
recommend
age,
understand
histori
normal
induc
healthcar
defin
concern
7
make
via
)
unit
strategi
school
epitheli
predict
covid-19.
futur
part
term
especi
mice
servic
questionnair
20
trial
pattern
screen
link
train
anxieti
main
post
(tabl
15
2020
cohort
reduct
point
analyz
often
furthermore,
averag
four
week
overal
receptor
known
variou
inflammatori
region
9
vs.
independ
18
lockdown
lack
take
combin
8
order
practic
interest
particl
manag
organ
regul
produc
moreover,
ratio
occur
presenc
grant
famili
direct
thus,
pandemic.
us
weight
24
distribut
aim
calcul
inhal
note
global
emerg
reveal
ci
reason
cultur
address
treat
healthi
record
particularli
older
covid-19,
sleep
frequent
baselin
h
example,
odd
scale
and/or
home
approv
life
psycholog
(fig.
fig.
14
exacerb
disord
explain
previous
discuss
item
food
2020.
either
engag
institut
account
comparison
recruit
;
addict
en
11
still
start
appear
valid
advers
restrict
diagnosi
interview
coronaviru
cardiovascular
disease,
local
moder
relev
motiv
key
last
use.
problem
incid
oral
follow-up
aerosol
second
place
(i.e.,
media
better
progress
youth
consent
attempt
percentag
pandemic,
highest
detail
never
16
despit
knowledg
1)
around
c
five
men
exist
author/funder,
+
line
expect
exclud
13
play
inflamm
consum
approxim
reflect
natur
patients.
devic
ad
•
singl
&
lifestyl
demograph
publish
appli
19
much
self-report
suscept
probabl
extract
code
sourc
benefit
peer
share
explor
thu
bodi
additionally,
comorbid
smokers,
electron
patients,
former
structur
alveolar
ill
finally,
offer
random
imag
intens
50
25
respect
sensit
(figur
surgic
non-smok
therapi
perpetuity.
critic
event
messag
toward
close
enhanc
million
establish
trend
pneumonia
cytokin
contact
isol
highli
sex
becom
articl
copyright
heart
21
q
household
creat
smoking.
vari
abl
alter
seen
member
experienc
success
holder
featur
dose
17
final
differenti
amount
injuri
center
focus
worker
poor
compon
influenza
employ
2019
0
logist
site
secondari
long-term
40
respectively.
inhibit
stage
criteria
2020;
literatur
wherea
2)
issu
pathway
focu
stop
median
mediat
index
govern
releas
diagnos
visit
2020,
anim
mask
22
(see
challeng
therefor
highlight
gender
attribut
cells,
le
parent
analysis.
bia
plan
(or
percept
systemat
(1)
correspond
monitor
confid
oxid
distanc
wide
separ
reach
rna
status,
usual
oxygen
subsequ
way
categor
maintain
spread
ethic
diabet
(2)
answer
carri
barrier
search
context
categori
durat
half
good
profession
23
complex
rather
environment
consequ
signal
studies,
damag
flavor
march
plant
smokers.
content
six
[5]
administr
obes
china
[4]
antibodi
seem
cluster
(which
resid
ec
miss
avoid
pressur
facilit
achiev
econom
loss
versu
28
predictor
[3]
distress
origin
taken
burden
count
syndrom
[6]
groups.
world
everi
declar
market
l
accept
guidelin
ever
underli
population.
abil
[13]
laboratori
awar
ci:
character
elev
sex,
[11]
[14]
[12]
strong
multivari
exercis
chemic
remov
industri
complic
face
[7]
protocol
26
project
vulner
[16]
larger
section
[9]
util
infection.
marijuana
list
descript
years,
uk
genet
substanti
appropri
ensur
27
transmiss
[10]
adapt
[1]
pollut
paramet
[8]
counsel
declin
resourc
effort
obstruct
b
[2]
4.0
right
younger
rat
31
bind
group.
materi
impair
directli
locat
[17]
integr
cross-sect
35
[15]
experiment
interpret
staff
compound
tool
applic
supplementari
procedur
cope
environ
financi
open
room
best
certifi
fit
f
phase
analysis,
admiss
sequenc
(95%
chest
act
u
get
data,
deriv
team
29
cost
long
incom
biolog
exclus
data.
oper
regular
[18]
host
1,
hour
almost
ventil
macrophag
e-cig
alreadi
propos
novel
dataset
[20]
se
el
transcript
group,
feel
certain
time,
first,
socioeconom
[19]
classifi
class
health,
qualit
must
nasal
serum
deliveri
inclus
3)
altern
breath
document
toxic
volum
sexual
occup
therapeut
diseases,
elig
[21]
habit
call
lo
enrol
opportun
similarly,
see
interv
tri
min
bronchial
modifi
fact
deliv
disease.
consider
infecti
along
typic
48
other
htp
action
particular
commonli
60
mainli
third
full
symptoms,
(3)
option
die
situat
mention
though
clear
[22]
32
outbreak
mild
upon
infection,
supplement
power
marker
acid
cannot
april
paper
),
flow
led
[23]
degre
cellular
longer
essenti
chines
colleg
2019)
review)
short
view
cours
exhal
cs
33
littl
except
central
app
ct
37
factors,
abstin
meet
american
45
dna
hiv
36
wave
profil
2,
combust
[24]
implic
minim
likelihood
mass
fund
34
<UNK>
